Protagonist Therapeutics, Inc. (PTGX) financial statements (2021 and earlier)

Company profile

Business Address 7707 GATEWAY BLVD., SUITE 140
NEWARK, CA 94560-1160
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments3061338214478
Cash and cash equivalents117338210621
Short-term investments188100 3857
Restricted cash and investments00000
Receivables4773 
Prepaid expense2210 
Other current assets   11
Other undisclosed current assets434725
Total current assets:31614513815183
Noncurrent Assets
Operating lease, right-of-use asset56
Property, plant and equipment12111
Long-term investments and receivables2  1110
Long-term investments2  1110
Restricted cash and investments0000 
Deferred income tax assets 1
Other noncurrent assets    0
Deferred tax assets, net1  
Total noncurrent assets:91021311
TOTAL ASSETS:32415513916494
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities221517116
Accounts payable33611
Accrued liabilities181211105
Deferred revenue1418
Debt 1   
Due to related parties311  
Contract with customer, liability8
Other undisclosed current liabilities1  32 
Total current liabilities:403526436
Noncurrent Liabilities
Long-term debt and lease obligation56   
Operating lease, liability56
Liabilities, other than long-term debt02411 
Deferred revenue and credits1 
Deferred revenue 24
Deferred rent credit  1
Other liabilities0    
Other undisclosed noncurrent liabilities 10   
Total noncurrent liabilities:54011 
Total liabilities:457527436
Stockholders' equity
Stockholders' equity attributable to parent2808011312188
Additional paid in capital563298253222152
Accumulated other comprehensive income (loss)0(0)(0)(0)(0)
Accumulated deficit(284)(218)(140)(102)(65)
Total stockholders' equity:2808011312188
TOTAL LIABILITIES AND EQUITY:32415513916494

Income statement (P&L) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
Revenue, net20 
Sublease income00
Gross profit:003120 
Operating expenses(93)(81)(73)(58)(33)
Other undisclosed operating income290   
Operating loss:(65)(81)(42)(38)(33)
Nonoperating income13310
Investment income, nonoperating13310
Other nonoperating expense(0)(0)  (0)
Interest and debt expense(1)(0)   
Loss from continuing operations before income taxes:(65)(78)(40)(37)(32)
Income tax expense (benefit)(1)1(1)  
Loss before gain (loss) on sale of properties:(66)(77)(41)(37)(32)
Other undisclosed net income  2  
Net loss:(66)(77)(39)(37)(32)
Other undisclosed net loss attributable to parent    (5)
Net loss attributable to parent:(66)(77)(39)(37)(37)
Preferred stock dividends and other adjustments    (1)
Net loss available to common stockholders, diluted:(66)(77)(39)(37)(38)

Comprehensive Income ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
Net loss:(66)(77)(39)(37)(32)
Other comprehensive loss    (0)
Comprehensive loss:(66)(77)(39)(37)(33)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent00(0)0(5)
Comprehensive loss, net of tax, attributable to parent:(66)(77)(39)(37)(37)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: